ADMA
Price
$17.26
Change
-$0.12 (-0.69%)
Updated
Aug 29 closing price
Capitalization
4.12B
64 days until earnings call
IRON
Price
$61.12
Change
+$1.47 (+2.46%)
Updated
Sep 2, 04:41 PM (EDT)
Capitalization
2.07B
65 days until earnings call
Interact to see
Advertisement

ADMA vs IRON

Header iconADMA vs IRON Comparison
Open Charts ADMA vs IRONBanner chart's image
ADMA Biologics
Price$17.26
Change-$0.12 (-0.69%)
Volume$2.53M
Capitalization4.12B
Disc Medicine
Price$61.12
Change+$1.47 (+2.46%)
Volume$100
Capitalization2.07B
ADMA vs IRON Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ADMA vs. IRON commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a Hold and IRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (ADMA: $17.26 vs. IRON: $59.65)
Brand notoriety: ADMA and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 85% vs. IRON: 64%
Market capitalization -- ADMA: $4.12B vs. IRON: $2.07B
ADMA [@Biotechnology] is valued at $4.12B. IRON’s [@Biotechnology] market capitalization is $2.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 2 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • ADMA’s FA Score: 2 green, 3 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, ADMA is a better buy in the long-term than IRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 3 TA indicator(s) are bullish while IRON’s TA Score has 5 bullish TA indicator(s).

  • ADMA’s TA Score: 3 bullish, 7 bearish.
  • IRON’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IRON is a better buy in the short-term than ADMA.

Price Growth

ADMA (@Biotechnology) experienced а -3.03% price change this week, while IRON (@Biotechnology) price change was -1.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

ADMA is expected to report earnings on Nov 05, 2025.

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.12B) has a higher market cap than IRON($2.07B). ADMA YTD gains are higher at: 0.641 vs. IRON (-5.923). ADMA has higher annual earnings (EBITDA): 163M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. ADMA (90.3M). IRON has less debt than ADMA: IRON (30.9M) vs ADMA (83.8M). ADMA has higher revenues than IRON: ADMA (474M) vs IRON (0).
ADMAIRONADMA / IRON
Capitalization4.12B2.07B199%
EBITDA163M-142.42M-114%
Gain YTD0.641-5.923-11%
P/E Ratio20.31N/A-
Revenue474M0-
Total Cash90.3M650M14%
Total Debt83.8M30.9M271%
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADMAIRON
RSI
ODDS (%)
Bearish Trend 5 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
71%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
78%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
77%
Bullish Trend 5 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
76%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
79%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
81%
Bullish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EPGFX16.240.47
+2.98%
EuroPac Gold A
FSTUX28.480.01
+0.04%
Invesco Dividend Income Investor
VILLX20.80-0.02
-0.10%
Villere Balanced Inv
NEWCX86.34-0.32
-0.37%
American Funds New World C
LMCRX32.99-0.17
-0.51%
Lord Abbett Mid Cap Stock R3

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with IMTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-0.69%
IMTX - ADMA
42%
Loosely correlated
-3.60%
IRON - ADMA
40%
Loosely correlated
-0.03%
IMNM - ADMA
39%
Loosely correlated
-3.94%
CPRX - ADMA
39%
Loosely correlated
+1.03%
SYRE - ADMA
38%
Loosely correlated
-1.38%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
-0.03%
SYRE - IRON
53%
Loosely correlated
-1.38%
CGON - IRON
51%
Loosely correlated
+0.39%
IDYA - IRON
51%
Loosely correlated
-1.52%
CRNX - IRON
50%
Loosely correlated
+1.11%
ERAS - IRON
50%
Loosely correlated
N/A
More